Drugs for inhibiting p38 and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9096554
APP PUB NO 20140296308A1
SERIAL NO

14355545

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds with a benzoxadiazolyl amine structure which are capable of inhibiting the activation or the biological activity of p38 mitogen-activated protein kinase (MAPK) and the use thereof in the treatment of a disease that can be alleviated by means of inhibiting the activation or the biological activity of said p38 MAPK, for example, an inflammatory disease or a disease presenting with pain.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSIDAD AUTONOMA DE MADRID28049 MADRID

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Campos, Muelas Pedro Manuel Madrid, ES 1 0
Gil, Redondo Rubén Madrid, ES 1 0
Heijnen, Jacoba Johana Madrid, ES 1 0
Kavelaars, Anna Maria Agnes Antonius Madrid, ES 1 0
Mayor, Menéndez Federico Madrid, ES 1 0
Morreale, de León Antonio Madrid, ES 3 1
Murga, Montesinos Cristina Madrid, ES 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 4, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00